Nanomedicine for the prevention, treatment and imaging of atherosclerosis

Maturitas

Volumn 73, Issue 1, 2012, Pages 52-60

  Psarros, Costas ^a   Lee, Regent ^a   Margaritis, Marios ^a   Antoniades, Charalambos ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Atherosclerosis; Drug delivery systems; Inflammation; Liposomes; Nanotechnology

Indexed keywords

5 (4 CARBOXYPHENYL) 10,15,20 TRIPHENYL 2,3 DIHYDROXYCHLORIN; APOLIPOPROTEIN B100; CHLORINE DERIVATIVE; CONTRAST MEDIUM; CYCLOPENTENONE DERIVATIVE; CYCLOPENTENONE PROSTAGLANDIN DERIVATIVE; DENDRIMER; DEXAMETHASONE; DEXTRAN; DIAMINOBUTANEDENDRIMER; FUMAGILLIN; GOLD NANOPARTICLE; IRON OXIDE; LIPOSOME; LOW DENSITY LIPOPROTEIN; MACROGOL; NANOCARRIER; NANOPARTICLE; POLYAMIDOAMINE; POLYAMIDOAMINEDENDRIMER; PREDNISOLONE 21 PHOSPHATE; PROSTAGLANDIN DERIVATIVE; QUANTUM DOT; SERUM AMYLOID A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ARTERY WALL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOCOMPATIBILITY; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; ECHOGRAPHY; FOAM CELL; GENE TARGETING; HUMAN; IMAGING SYSTEM; MACROPHAGE; NANODEVICE; NANOMEDICINE; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREVENTION STUDY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NANOPARTICLES;

EID: 84864999594     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.12.014     Document Type: Review

References (91)

1. J. Mackay, and G. Mensah Atlas of heart disease and stroke 2004 World Health Organization (WHO), Geneva Press
2. C. Antoniades, A.S. Antonopoulos, J.K. Bendall, and K.M. Channon Targeting redox signaling in the vascular wall: from basic science to clinical practice Curr Pharm Des 15 2009 329 342
3. R. Stocker, and J.F. Keaney Jr. Role of oxidative modifications in atherosclerosis Physiol Rev 84 2004 1381 1478 (Pubitemid 39302636)
4. M. Naghavi, P. Libby, and E. Falk From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I Circulation 108 2003 1664 1672 (Pubitemid 37243650)
5. M. Goldberg, R. Langer, and X. Jia Nanostructured materials for applications in drug delivery and tissue engineering J Biomater Sci Polym Ed 18 2007 241 268 (Pubitemid 46403135)
6. C. Antoniades, C. Psarros, D. Tousoulis, C. Bakogiannis, C. Shirodaria, and C. Stefanadis Nanoparticles a promising therapeutic approach in atherosclerosis Cancer Drug Deliv 7 2010 303 311
7. R.K. Jain Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function J Control Release 74 2001 7 25 (Pubitemid 32727605)
8. L.Y. Qiu, and Y.H. Bae Polymer architecture drug delivery Pharm Res 23 2006 1 30
9. R.A. Schwendener Liposomes in biology and medicine Adv Exp Med Biol 620 2007 117 128
10. D.A. Christian, S. Cai, D.M. Bowen, Y. Kim, J.D. Pajerowski, and D.E. Discher Polymersome carriers: from self-assembly to siRNA and protein therapeutics Eur J Pharm Biopharm 71 2009 463 474
11. J.M. Harris, and R.B. Chess Effect of pegylation on pharmaceuticals Nat Rev Drug Discov 2 2003 214 221 (Pubitemid 37361666)
12. J. Shin, P. Shum, and D.H. Thompson Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids J Control Release 91 2003 187 200 (Pubitemid 37288890)
13. S. Zalipsky, M. Qazen, J.A. Walker 2nd, N. Mullah, Y.P. Quinn, and S.K. Huang New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine Bioconjug Chem 10 1999 703 707 (Pubitemid 29456355)
14. T. Rhen, and J.A. Cidlowski Antiinflammatory action of glucocorticoids - new mechanisms for old drugs N Engl J Med 353 2005 1711 1723
15. C.J. Pepine, J.W. Hirshfeld, and R.G. Macdonald A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group Circulation 81 1990 1753 1761 (Pubitemid 20183823)
16. G.W. Stone, B.D. Rutherford, and D.R. McConahay A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty Catheter Cardiovasc Diagn 18 1989 227 231 (Pubitemid 20088550)
17. M. Joner, K. Morimoto, and H. Kasukawa Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma Arterioscler Thromb Vasc Biol 28 2008 1960 1966
18. K.J. Woollard, and F. Geissmann Monocytes in atherosclerosis: subsets and functions Nat Rev Cardiol 7 2010 77 86
19. S. Chono, Y. Tauchi, Y. Deguchi, and K. Morimoto Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice J Drug Target 13 2005 267 276 (Pubitemid 41086291)
20. S. Chono, Y. Tauchi, and K. Morimoto Pharmacokinetic analysis of the uptake of liposomes by macrophages and foam cells in vitro and their distribution to atherosclerotic lesions in mice Drug Metab Pharmacokinet 21 2006 37 44
21. P.I. Homem de Bittencourt Jr., D.J. Lagranha, and A. Maslinkiewicz LipoCardium: endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions Atherosclerosis 193 2007 245 258 (Pubitemid 47064399)
22. S.P. Tam, J.B. Ancsin, R. Tan, and R. Kisilevsky Peptides derived from serum amyloid A prevent, and reverse, aortic lipid lesions in apoE-/- mice J Lipid Res 46 2005 2091 2101 (Pubitemid 41377461)
23. R. Duncan The dawning era of polymer therapeutics Nat Rev Drug Discov 2 2003 347 360 (Pubitemid 37361705)
24. S. Brocchini, and R. Duncan Encyclopaedia of controlled drug delivery 1999 Wiley New York, NY
25. T. Peng, and Y.L. Cheng Polymer 42 2001 2091
26. R. Duncan, and F. Spreafico Polymer conjugates. Pharmacokinetic considerations for design and development Clin Pharmacokinet 27 1994 290 306 (Pubitemid 24315088)
27. M.P. Desai, V. Labhasetwar, G.L. Amidon, and R.J. Levy Gastrointestinal uptake of biodegradable microparticles: effect of particle size Pharm Res 13 1996 1838 1845 (Pubitemid 27034116)
28. P.J. Photos, L. Bacakova, B. Discher, F.S. Bates, and D.E. Discher Polymer vesicles in vivo: correlations with PEG molecular weight J Control Release 90 2003 323 334 (Pubitemid 36859964)
29. S.M. Moghimi, and J. Szebeni Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog Lipid Res 42 2003 463 478 (Pubitemid 37237636)
30. W.J. Mulder, G.J. Strijkers, and K.C. Briley-Saboe Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles Magn Reson Med 58 2007 1164 1170 (Pubitemid 350234203)
31. K.C. Briley-Saebo, P.X. Shaw, and W.J. Mulder Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes Circulation 117 2008 3206 3215
32. P.M. Winter, A.M. Neubauer, and S.D. Caruthers Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis Arterioscler Thromb Vasc Biol 26 2006 2103 2109 (Pubitemid 44253795)
33. P.M. Winter, S.D. Caruthers, and A. Kassner Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging Cancer Res 63 2003 5838 5843 (Pubitemid 37187482)
34. C. Antoniades, C. Psarros, D. Tousoulis, C. Bakogiannis, C. Shirodaria, and C. Stefanadis Nanoparticles: a promising therapeutic approach in atherosclerosis Cancer Drug Deliv 7 2010 303 311
35. E. Chnari, H.B. Lari, L. Tian, K.E. Uhrich, and P.V. Moghe Nanoscale anionic macromolecules for selective retention of low-density lipoproteins Biomaterials 26 2005 3749 3758 (Pubitemid 40038170)
36. T. Nagle, C. Berg, R. Nassr, and K. Pang The further evolution of biotech Nat Rev Drug Discov 2 2003 75 79 (Pubitemid 37361627)
37. C. Delgado, G.E. Francis, and D. Fisher The uses and properties of PEG-linked proteins Crit Rev Ther Drug Carrier Syst 9 1992 249 304
38. A.P. Chapman, P. Antoniw, M. Spitali, S. West, S. Stephens, and D.J. King Therapeutic antibody fragments with prolonged in vivo half-lives Nat Biotechnol 17 1999 780 783 (Pubitemid 29365106)
39. R.J. Goodson, and N.V. Katre Site-directed pegylation of recombinant interleukin-2 at its glycosylation site Biotechnology (NY) 8 1990 343 346 (Pubitemid 20138305)
40. H. Sato Enzymatic procedure for site-specific pegylation of proteins Adv Drug Deliv Rev 54 2002 487 504 (Pubitemid 34615545)
41. E.N. Atochina, I.V. Balyasnikova, S.M. Danilov, D.N. Granger, A.B. Fisher, and V.R. Muzykantov Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress Am J Physiol 275 1998 L806 L817
42. M. Christofidou-Solomidou, A. Scherpereel, and R. Wiewrodt PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress Am J Physiol Lung Cell Mol Physiol 285 2003 L283 L292
43. R. Wiewrodt, A.P. Thomas, and L. Cipelletti Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells Blood 99 2002 912 922 (Pubitemid 34525553)
44. C. Antoniades, C. Bakogiannis, and D. Tousoulis Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity Circulation 122 2010 S66 S73
45. S. Dikalov Cross talk between mitochondria and NADPH oxidases Free Radic Biol Med 2011
46. V.D. Maximov, V.V. Reukov, J.N. Barry, C. Cochrane, and A.A. Vertegel Protein-nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia Nanotechnology 21 2010 265103
47. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806 811 (Pubitemid 28099681)
48. Y. Wang, Z. Li, Y. Han, L.H. Liang, and A. Ji Nanoparticle-based delivery system for application of siRNA in vivo Curr Drug Metab 11 2010 182 196
49. J.M. Li, X. Zhang, and P.R. Nelson Temporal evolution of gene expression in rat carotid artery following balloon angioplasty J Cell Biochem 101 2007 399 410 (Pubitemid 46698874)
50. H. Kroto, J.R. Heath, S.C. OBrien, R.F. Curl, and R.E. Smalley C60: buckminster fullerene Nature 318 1985 162 163
51. R. Bakry, R.M. Vallant, and M. Najam-ul-Haq Medicinal applications of fullerenes Int J Nanomed 2 2007 639 649
52. L. Xiao, H. Aoshima, Y. Saitoh, and N. Miwa Highly hydroxylated fullerene localizes at the cytoskeleton and inhibits oxidative stress in adipocytes and a subcutaneous adipose-tissue equivalent Free Radic Biol Med 2011
53. H.C. Hsu, Y.Y. Chiang, W.J. Chen, and Y.T. Lee Water-soluble hexasulfobutyl 60 fullerene inhibits plasma lipid peroxidation by direct association with lipoproteins J Cardiovasc Pharmacol 36 2000 423 427
54. R. Maeda, E. Noiri, and H. Isobe A water-soluble fullerene vesicle alleviates angiotensin II-induced oxidative stress in human umbilical venous endothelial cells Hypertens Res 31 2008 141 151 (Pubitemid 351325626)
55. V.G. Walker, Z. Li, T. Hulderman, D. Schwegler-Berry, M.L. Kashon, and P.P. Simeonova Potential in vitro effects of carbon nanotubes on human aortic endothelial cells Toxicol Appl Pharmacol 236 2009 319 328
56. Y. Niwa, and N. Iwai Nanomaterials induce oxidized low-density lipoprotein cellular uptake in macrophages and platelet aggregation Circ J 71 2007 437 444 (Pubitemid 46409551)
57. P. Moller, L. Mikkelsen, and L.K. Vesterdal Hazard identification of particulate matter on vasomotor dysfunction and progression of atherosclerosis Crit Rev Toxicol 41 2011 339 368
58. P.P. Simeonova, and A. Erdely Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers Inhal Toxicol 21 Suppl. 1 2009 68 73
59. S.A. Wickline, A.M. Neubauer, P.M. Winter, S.D. Caruthers, and G.M. Lanza Molecular imaging and therapy of atherosclerosis with targeted nanoparticles J Magn Reson Imaging 25 2007 667 680 (Pubitemid 46516717)
60. S.M. Demos, H. Alkan-Onyuksel, and B.J. Kane In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement J Am Coll Cardiol 33 1999 867 875
61. H. Kobayashi, S. Kawamoto, S.K. Jo, H.L. Bryant Jr., M.W. Brechbiel, and R.A. Star Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores Bioconjug Chem 14 2003 388 394 (Pubitemid 36348662)
62. N. Sato, H. Kobayashi, and A. Hiraga Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores Magn Reson Med 46 2001 1169 1173 (Pubitemid 33104305)
63. C. Loo, A. Lin, and L. Hirsch Nanoshell-enabled photonics-based imaging and therapy of cancer Technol Cancer Res Treat 3 2004 33 40 (Pubitemid 38250466)
64. X. Michalet, F.F. Pinaud, and L.A. Bentolila Quantum dots for live cells, in vivo imaging, and diagnostics Science 307 2005 538 544 (Pubitemid 40165671)
65. M.A. McAteer, C. von Zur Muhlen, D.C. Anthony, N.R. Sibson, and R.P. Choudhury Magnetic resonance imaging of brain inflammation using microparticles of iron oxide Methods Mol Biol 680 2011 103 115
66. S.A. Schmitz, S.E. Coupland, and R. Gust Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits Invest Radiol 35 2000 460 471 (Pubitemid 30622013)
67. J.R. McCarthy, F.A. Jaffer, and R. Weissleder A macrophage-targeted theranostic nanoparticle for biomedical applications Small 2 2006 983 987 (Pubitemid 44230996)
68. R.S. Vasan Biomarkers of cardiovascular disease: molecular basis and practical considerations Circulation 113 2006 2335 2362 (Pubitemid 43947980)
69. J. Danesh, J.G. Wheeler, and G.M. Hirschfield C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397 (Pubitemid 38419992)
70. A.A. Mangoni, and S.H. Jackson Homocysteine cardiovascular disease: current evidence future prospects Am J Med 112 2002 556 565 (Pubitemid 34518316)
71. T.J. Wang, P. Gona, and M.G. Larson Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 2006 2631 2639 (Pubitemid 44969122)
72. Y. Cui, Q. Wei, H. Park, and C.M. Lieber Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species Science 293 2001 1289 1292 (Pubitemid 32777412)
73. J. Wang, B. Hong, and J. Kai Mini sensing chip for point-of-care acute myocardial infarction diagnosis utilizing micro-electro-mechanical system and nano-technology Adv Exp Med Biol 645 2009 101 107
74. S. Vogt, D. Troitzsch, S. Spath, and R. Moosdorf Efficacy of ion-selective probes in early epicardial in vivo detection of myocardial ischemia Physiol Meas 25 2004 N21 N26
75. M. Sato, T. Nakajima, M. Goto, and Y. Umezawa Cell-based indicator to visualize picomolar dynamics of nitric oxide release from living cells Anal Chem 78 2006 8175 8182 (Pubitemid 44927592)
76. T.K. Hsiai, M. Rouhanizadeh, T. Tang, C. Li, J.L. Hwang, and C.W. Zhou Differentiation of oxidized low density lipoproteins by nanosensors Sens Actuators B: Chem 114 2006 788 798
77. A. Magrez, S. Kasas, and V. Salicio Cellular toxicity of carbon-based nanomaterials Nano Lett 6 2006 1121 1125 (Pubitemid 44013471)
78. S.T. Stern, and S.E. McNeil Nanotechnology safety concerns revisited Toxicol Sci 101 2008 4 21 (Pubitemid 350239008)
79. B.S. Zolnik, A. Gonzalez-Fernandez, N. Sadrieh, and M.A. Dobrovolskaia Nanoparticles and the immune system Endocrinology 151 2010 458 465
80. M.A. Dobrovolskaia, P. Aggarwal, J.B. Hall, and S.E. McNeil Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution Mol Pharmacol 5 2008 487 495
81. S. Bosi, L. Feruglio, and T. Da Ros Hemolytic effects of water-soluble fullerene derivatives J Med Chem 47 2004 6711 6715 (Pubitemid 40053760)
82. D.M. Domanski, B. Klajnert, and M. Bryszewska Influence of PAMAM dendrimers on human red blood cells Bioelectrochemistry 63 2004 189 191 (Pubitemid 38534218)
83. D.S. Shah, T. Sakthivel, I. Toth, A.T. Florence, and A.F. Wilderspin DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers Int J Pharm 208 2000 41 48
84. A. Radomski, P. Jurasz, and D. Alonso-Escolano Nanoparticle-induced platelet aggregation and vascular thrombosis Br J Pharmacol 146 2005 882 893 (Pubitemid 41622255)
85. P. Aggarwal, J.B. Hall, C.B. McLeland, M.A. Dobrovolskaia, and S.E. McNeil Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Adv Drug Deliv Rev 61 2009 428 437
86. T. Ishida, X. Wang, T. Shimizu, K. Nawata, and H. Kiwada PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner J Control Release 122 2007 349 355 (Pubitemid 47407760)
87. X. Wang, T. Ishida, and H. Kiwada Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes J Control Release 119 2007 236 244 (Pubitemid 46759557)
88. B.X. Chen, S.R. Wilson, M. Das, D.J. Coughlin, and B.F. Erlanger Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics Proc Natl Acad Sci USA 95 1998 10809 10813 (Pubitemid 28413150)
89. O. Al-Hanbali, K.J. Rutt, D.K. Sarker, A.C. Hunter, and S.M. Moghimi Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption J Nanosci Nanotechnol 6 2006 3126 3133 (Pubitemid 44579991)
90. I. Bertholon, C. Vauthier, and D. Labarre Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide Pharm Res 23 2006 1313 1323 (Pubitemid 43946153)
91. A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J.C. Leroux, and J.P. Benoit Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake J Biomed Mater Res A 78 2006 620 628 (Pubitemid 44253547)